🔴 Anixa Biosciences is trading 5% down today as Nasdaq and S&P 500 also fell

Anixa Biosciences is trading at $3.13, with a -5.15% change on October 30, 2026, amid broader market pressure; available evidence does not establish a direct cause for the decline.

• A market report showed the Nasdaq down 2.65% and the S&P 500 down 1.64% on October 30.
• No new company-specific announcement explaining the decline was found. The latest company release identified in the search was October 26, about its ovarian cancer CAR-T trial.